Sponsored
Discover how a new mid-scale DynaDrive™ bioreactor platform and KojoX™ philosophy are redefining supply-chain security and manufacturing consistency across a growing global network.
Daniella Cramp, Thermo Fisher Scientific
Advertisement
Daniella Cramp
Sr. VP and President, Bioproduction Group
Thermo Fisher Scientific
Articles by Daniella Cramp, Thermo Fisher Scientific
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
2
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
3
AAPS PharmSci 360: How USP Is Tackling the Novel Excipient Roadblock
4
Why Drug Shortages Average 5+ Years: PharmTech Explained
5